Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Funds Aren’t Crazy About CareFusion Corporation (NYSE:CFN) Anymore

Is CareFusion Corporation (NYSE:CFN) a cheap investment today? Investors who are in the know are taking a pessimistic view. The number of bullish hedge fund bets stayed the same which is a slightly negative development in our experience

In today’s marketplace, there are plenty of metrics shareholders can use to monitor publicly traded companies. A pair of the most under-the-radar are hedge fund and insider trading interest. At Insider Monkey, our studies have shown that, historically, those who follow the top picks of the elite fund managers can outperform their index-focused peers by a healthy margin (see just how much).


Just as beneficial, bullish insider trading sentiment is a second way to parse down the investments you’re interested in. There are a number of incentives for an insider to drop shares of his or her company, but only one, very simple reason why they would buy. Various academic studies have demonstrated the valuable potential of this method if “monkeys” know where to look (learn more here).

With all of this in mind, let’s take a look at the key action surrounding CareFusion Corporation (NYSE:CFN).

What does the smart money think about CareFusion Corporation (NYSE:CFN)?

At the end of the fourth quarter, a total of 28 of the hedge funds we track held long positions in this stock, a change of 0% from the third quarter. With the smart money’s sentiment swirling, there exists a select group of notable hedge fund managers who were boosting their stakes considerably.

When looking at the hedgies we track, Arrowstreet Capital, managed by Peter Rathjens, Bruce Clarke and John Campbell, holds the largest position in CareFusion Corporation (NYSE:CFN). Arrowstreet Capital has a $143 million billion position in the stock, comprising 0.7% of its 13F portfolio. The second largest stake is held by Cadian Capital, managed by Eric Bannasch, which held a $106 million position; 0.7% of its 13F portfolio is allocated to the stock. Some other peers that hold long positions include Ricky Sandler’s Eminence Capital, Lee Ainslie’s Maverick Capital and David Costen Haley’s HBK Investments.

Judging by the fact that CareFusion Corporation (NYSE:CFN) has faced falling interest from hedge fund managers, logic holds that there is a sect of fund managers that elected to cut their positions entirely in Q4. Intriguingly, Robert Rodriguez and Steven Romick’s First Pacific Advisors LLC sold off the biggest position of the “upper crust” of funds we track, valued at an estimated $140 million in stock.. David Gallo’s fund, Valinor Management LLC, also dumped its stock, about $11 million worth. These moves are important to note, as total hedge fund interest stayed the same (this is a bearish signal in our experience).

What do corporate executives and insiders think about CareFusion Corporation (NYSE:CFN)?

Insider buying is particularly usable when the primary stock in question has seen transactions within the past 180 days. Over the last 180-day time frame, CareFusion Corporation (NYSE:CFN) has experienced zero unique insiders purchasing, and 5 insider sales (see the details of insider trades here).

With the returns exhibited by the aforementioned studies, retail investors must always monitor hedge fund and insider trading sentiment, and CareFusion Corporation (NYSE:CFN) shareholders fit into this picture quite nicely.

Click here to learn more about Insider Monkey’s Hedge Fund Newsletter

Insider Monkey’s small-cap strategy returned 29.2% between September 2012 and February 2013 versus 8.7% for the S&P 500 index. Try it now by clicking the link above.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!